Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 30 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-23 | 3 co-filers EVP, Chief Financial Officer | Option exercise | 332 | $0.00 | $0 |
| 2026-10-23 | 3 co-filers EVP, Chief Financial Officer | Tax withholding | 117 | $41.19 | $5k |
| 2026-10-23 | 3 co-filers EVP, Chief Financial Officer | Option exercise | 332 | $0.00 | — |
| 2026-10-06 | 8 co-filers Group filing | Option exercise |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 561 |
| $26.41 |
| $15k |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 697 | $23.54 | $16k |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 850 | $24.20 | $21k |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 1,000 | $30.51 | $31k |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 561 | $0.00 | — |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 697 | $0.00 | — |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 850 | $0.00 | — |
| 2026-10-06 | 8 co-filers Group filing | Option exercise | 1,000 | $0.00 | — |
| 2026-09-29 | 3 co-filers Group filing | Option exercise | 2,750 | $26.41 | $73k |
| 2026-09-29 | 3 co-filers Group filing | Tax withholding | 2,011 | $36.12 | $73k |
| 2026-09-29 | 3 co-filers Group filing | Option exercise | 2,750 | $0.00 | — |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 2,250 | $26.41 | $59k |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 2,616 | $23.54 | $62k |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 1,700 | $24.20 | $41k |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 1,000 | $30.51 | $31k |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 2,250 | $0.00 | — |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 2,616 | $0.00 | — |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 1,700 | $0.00 | — |
| 2026-09-28 | 8 co-filers Group filing | Option exercise | 1,000 | $0.00 | — |
| 2026-09-25 | 3 co-filers Group filing | Option exercise16d late | 1,800 | $26.41 | $48k |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 2,250 | $26.41 | $59k |
| 2026-09-25 | 3 co-filers Group filing | Tax withholding16d late | 1,322 | $35.98 | $48k |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 2,616 | $23.54 | $62k |
| 2026-09-25 | 3 co-filers Group filing | Option exercise16d late | 1,800 | $0.00 | — |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 1,700 | $24.20 | $41k |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 1,000 | $30.51 | $31k |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 2,250 | $0.00 | — |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 2,616 | $0.00 | — |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 1,700 | $0.00 | — |
| 2026-09-25 | 8 co-filers Group filing | Option exercise | 1,000 | $0.00 | — |
| 2026-09-24 | 2 co-filers Group filing | Option exercise | 2,250 | $26.41 | $59k |
| 2026-09-24 | 2 co-filers Group filing | Option exercise | 2,250 | $0.00 | — |
| 2026-09-23 | 2 co-filers Group filing | Option exerciseindirect | 2,250 | $26.41 | $59k |
| 2026-09-23 | 4 co-filers Group filing | Option exercise | 646 | $16.09 | $10k |
| 2026-09-23 | 2 co-filers Group filing | Option exercise | 2,250 | $0.00 | — |
| 2026-09-23 | 4 co-filers Group filing | Option exercise | 375 | $30.51 | $11k |
| 2026-09-23 | 4 co-filers Group filing | Option exercise | 646 | $0.00 | — |
A reverse discounted cash flow is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 11% of free cash flow, leaving room to grow it and fund buybacks. Last year: $7.3M dividends + $11.7M buybacks = $19.0M returned on $67.3M FCF.
5 consecutive years of dividend increases · 46%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 9 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Insufficient data. Current ROIC on all capital: 14%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 9 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
Where each multiple sits in its own 8-yr range · 88th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 8-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 14% against ROIC 14% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CBNK: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Leverage ratios is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | — | -$3.7M | -$4.6M | -$4.5M | — | — | — | — | — |
| Interest Expense | — | — | $41.7M | $10.0M | $6.5M | $13.2M | $15.8M | $11.2M | $7.8M |
| Pretax Income | $74.9M | $41.8M | $46.2M | $54.2M | $53.9M | $35.1M | $22.7M | $17.7M | $14.1M |
| Income Tax Expense | $17.8M | $10.9M | $10.4M | $12.4M | $13.9M | $9.3M | $5.8M | $5.0M | $7.0M |
| Net Income | $57.2M | $31.0M | $35.9M | $41.8M | $40.0M | $25.8M | $16.9M | $12.8M | $7.1M |
| Per Share | |||||||||
| EPS (Basic) | $3.45 | $2.12 | $2.56 | $2.98 | $2.90 | $1.87 | $1.23 | $1.05 | $0.63 |
| EPS (Diluted) | $3.41 | $2.12 | $2.55 | $2.91 | $2.84 | $1.87 | $1.21 | $1.02 | $0.62 |
| Weighted Avg Shares (Basic) | 16.6M | 14.6M | 14.0M | 14.0M | 13.8M | 13.8M | 13.7M | 12.1M | 11.3M |
| Weighted Avg Shares (Diluted) | 16.8M | 14.6M | 14.1M | 14.4M | 14.1M | 13.8M | 14.0M | 12.5M | 11.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 16 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JPM | $895.0B | 16.8× | — | 4.9× | 2.8% | — | 31.3% | 15.7% | 13.4% | — | 1,974 |
| BAC | $346.2B | 13.1× | — | 3.1× | 6.8% | — | 27.0% | 10.1% | 4.9% | — | 1,281 |
| C | $203.0B | 17.6× | — | 2.4× | 5.6% | — | 16.8% | 6.7% | 2.5% | — | — |
| COF | $125.7B | 50.8× | — | 2.4× | 36.6% | — | 4.6% | 2.2% | 2.1% | — | 645 |
| USB | $92.6B | 12.9× | — | 3.2× | 4.4% | — | 26.4% | 11.6% | 9.2% | — | 685 |
| PNC | $90.5B | 13.7× | — | 3.9× | 7.2% | — | 30.3% | 11.5% | 5.9% | — | 677 |
| KEY | $22.3B | 13.9× | — | 3.0× | 62.7% | — | 24.3% | 9.0% | 6.0% | — | 248 |
| FHN | $11.0B | 12.4× | — | 3.2× | 7.2% | — | 28.7% | 11.1% | 8.1% | — | — |
| CFR | $9.8B | 15.9× | — | 4.4× | 8.3% | — | 29.0% | 14.2% | 14.2% | — | 149 |
| WBHC | $6.8B | 87.9× | — | 19.1× | 14.2% | — | 21.2% | 13.0% | 12.8% | — | — |
| CBU | $3.3B | 15.7× | — | 4.0× | 9.6% | — | 25.7% | 10.5% | 10.5% | — | 58 |
| PRK | $3.2B | 15.8× | — | 4.8× | 2.9% | — | 27.1% | 13.3% | 12.6% | — | 61 |
| BANC | $2.9B | 15.6× | — | 1.6× | -3.8% | — | 12.6% | 6.5% | 4.1% | — | 48 |
| NBTB | $2.7B | 15.7× | — | 14.8× | 10.4% | — | 92.5% | 8.9% | 8.3% | — | 62 |
| CASH | $1.6B | 9.6× | — | 1.9× | 5.3% | — | 22.1% | 21.7% | 20.6% | — | 46 |
| HAFC | $960M | 13.0× | 12.1× | 3.5× | 15.3% | — | 28.2% | 9.6% | 9.6% | 0.0× | 38 |
| CBNK | $681M | 12.2× | — | — | — | — | — | 14.2% | 14.2% | — | 27 |
Peers = companies sharing CBNK's sector (National Commercial Banks) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
Return on equity (14%) and return on invested capital (14%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Converts 1.60x of reported profit into free cash flow over 5 years, with accruals negative.
Shares outstanding are up 18% since FY2019 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Leverage is not measurable this way for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $41.72, free cash flow must compound 2.89%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | 2444.4% | 2.9% |
| FY2022 | −62.3% | 2.9% |
| FY2023 | −9.2% | 2.9% |
| FY2024 | −27.6% | 2.9% |
| FY2025 | 105.5% | 2.9% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
| Step | Amount | Running total |
|---|---|---|
| Net income | $57M | $57M |
| Share-based comp | $2M | $59M |
| Other non-cash & working capital | $11M | $70M |
| Operating cash flow | $70M | $70M |
| Capex | −$2M | $67M |
| Free cash flow | $67M | $67M |
| FCF after SBC | $66M | $66M |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | 3.1 percent |
| FY2020 | 1.1 percent |
| FY2021 | -4.5 percent |
| FY2022 | -0.5 percent |
| FY2023 | -0.5 percent |
| FY2024 | -0.1 percent |
| FY2025 | -0.3 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.